Colon cancer molecular subtypes identified by expression profiling and associated to stroma, mucinous type and different clinical behavior.
about
Molecular pathological classification of colorectal cancerGenome-wide analysis of microRNA and mRNA expression signatures in cancerThe more the messier: centrosome amplification as a novel biomarker for personalized treatment of colorectal cancersColorectal Cancer Classification and Cell Heterogeneity: A Systems Oncology ApproachTranslating genomic profiling to gastrointestinal cancer treatment.A novel pathway-based distance score enhances assessment of disease heterogeneity in gene expression.Molecular landscape and sub-classification of gastrointestinal cancers: a review of literature.A 5-gene classifier from the carcinoma-associated fibroblast transcriptomic profile and clinical outcome in colorectal cancer.Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transitionSubtypes of primary colorectal tumors correlate with response to targeted treatment in colorectal cell linesHallmarks in colorectal cancer: angiogenesis and cancer stem-like cellsImplications of epithelial-mesenchymal plasticity for heterogeneity in colorectal cancer.Gene signatures of drug resistance predict patient survival in colorectal cancerTissue-specific patterns of gene expression in the epithelium and stroma of normal colon in healthy individuals in an aspirin intervention trial.The prognostic value of the stem-like group in colorectal cancer using a panel of immunohistochemistry markersThe consensus molecular subtypes of colorectal cancerDevelopment of a deregulating microRNA panel for the detection of early relapse in postoperative colorectal cancer patients.A colorectal cancer classification system that associates cellular phenotype and responses to therapyGene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer.Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.Prognostic biomarkers in colorectal cancer: where do we stand?Accuracy of TNM staging in colorectal cancer: a review of current culprits, the modern role of morphology and stepping-stones for improvements in the molecular era.Current controversies in the management of metastatic colorectal cancer.Collagen-rich stroma in aggressive colon tumors induces mesenchymal gene expression and tumor cell invasion.Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance.TGFβ signaling directs serrated adenomas to the mesenchymal colorectal cancer subtype.Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer.High Intratumoral Stromal Content Defines Reactive Breast Cancer as a Low-risk Breast Cancer Subtype.Molecular genetics of colorectal cancer.Validation of the 12-gene colon cancer recurrence score as a predictor of recurrence risk in stage II and III rectal cancer patients.Prognostic impact of a novel gene expression profile classifier for the discrimination between metastatic and non-metastatic primary colorectal cancer tumors.Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models.SOD3 improves the tumor response to chemotherapy by stabilizing endothelial HIF-2α.Gene expression profiling-derived immunohistochemistry signature with high prognostic value in colorectal carcinoma.Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells.Intrinsic cancer subtypes-next steps into personalized medicineUnsupervised analyses reveal molecular subtypes associated to prognosis and response to therapy in colorectal cancerPrognosis and Therapeutic Implications for Emerging Colorectal Cancer Subtypes
P2860
Q26744251-17ABFC69-D72C-4263-B1E8-702468E62334Q26795603-D6F7334F-4774-4F02-ABD8-D568624FAE00Q28072910-E2915A6B-642C-4DC3-B830-653442FE6E01Q28647615-9F517B3D-622D-4438-9007-2B31333EB729Q30239109-005C1668-796E-4B7E-9D21-80A963C4F14DQ33823764-C13B309D-F2E9-46DD-A04D-35E3DAED6B5CQ33895591-BA6DAE57-F6B9-44F0-9FB0-CE62DF4520A2Q34227755-702586BA-CEF7-49F4-AA28-CB5148400CC9Q34522228-0D3B4F7A-0895-4263-95FC-4FA8308DEAADQ34526671-87B473E4-46D7-4403-907D-D42E6C1A48CDQ34661510-560A1C3D-71F5-434D-9527-5EC7F3E70518Q35037258-114F3E97-72BD-4250-A676-EA52B3FD6A59Q35237150-31CB90C9-9A82-4F00-A206-60214FF938DBQ35576759-0A569188-D30C-4CF5-A2C4-8CFF145FCA10Q35828678-81A99FB2-7D7D-4373-86BC-05F3B7F993B6Q36258187-8DD827F6-BC29-4796-AEDB-FA701D57A828Q36850977-5D33F25D-A08B-4BCD-A2FD-668D166C1B61Q37175913-01F53CB4-77DB-4B4C-B829-AEAA4848F514Q37343279-9C9FC3E5-E281-48B7-B102-C662D21F7B04Q37610799-1ED65139-17D3-4255-8A7B-CA32452C4EA7Q38184378-4D23645C-7E80-49C6-BE6A-CC7A927FD589Q38241953-825527C4-01CC-4451-973A-6CFBC1E6A6DBQ38538213-7E11325E-2BF1-4175-8CB7-CFABE77037BBQ38784679-5F88B93C-7F40-4377-81D0-2FA6AB9B74ECQ38901400-0CB8B1CB-050E-45DB-9CB0-B19369EFF3D8Q39739202-72213443-2990-4D86-A6E3-4DEDC4A3E622Q40953655-341F603F-E345-485B-AF0B-7E55ECBB037DQ42370969-778FCD5E-C140-4E1B-9AD9-BE483165A7FCQ42406512-8A1E830D-9F93-4896-8988-5EFE22099021Q44641112-AD5B0E69-F2A4-426C-B9FA-3FB98DA34E73Q47125672-8E34FAB4-3BFD-4A07-896B-6BA366B2D72AQ47203432-507202F1-80AF-461D-AAB7-F09DA3FA55DEQ50107305-5E1503E5-64DE-4378-8B33-682FCC207296Q54237552-AE16B200-777D-460B-8545-BBA5F99CC992Q55411157-DE326CA2-D54B-4E1A-83D5-1449B3ADB429Q58053534-5278A3FA-EA80-42C4-9429-333E8A94E8A8Q58053541-9100A445-9BA9-45F8-9EF8-54BD66D8A3DFQ58614422-412AA018-311A-44C6-A279-A6B9ACB621FA
P2860
Colon cancer molecular subtypes identified by expression profiling and associated to stroma, mucinous type and different clinical behavior.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Colon cancer molecular subtype ...... d different clinical behavior.
@ast
Colon cancer molecular subtype ...... d different clinical behavior.
@en
Colon cancer molecular subtype ...... d different clinical behavior.
@nl
type
label
Colon cancer molecular subtype ...... d different clinical behavior.
@ast
Colon cancer molecular subtype ...... d different clinical behavior.
@en
Colon cancer molecular subtype ...... d different clinical behavior.
@nl
prefLabel
Colon cancer molecular subtype ...... d different clinical behavior.
@ast
Colon cancer molecular subtype ...... d different clinical behavior.
@en
Colon cancer molecular subtype ...... d different clinical behavior.
@nl
P2093
P2860
P50
P356
P1433
P1476
Colon cancer molecular subtype ...... nd different clinical behavior
@en
P2093
Alejandro Romera-Lopez
Beatriz Perez-Villamil
Javier Sastre
Jose-Antonio Lopez-Asenjo
Julian Sanz-Ortega
Rosario Alfonso
Susana Hernandez-Prieto
Trinidad Caldes
P2860
P2888
P356
10.1186/1471-2407-12-260
P407
P50
P577
2012-06-19T00:00:00Z
P5875
P6179
1002290143